The total worth of the marijuana market will reach US$166 billion by 2025, according to a market report made public on Tuesday (February 26) from Euromonitor International.
The firm expects legal cannabis to represent over 70 percent of the total market globally by the target date.
Zora Milenkovic, head of drinks and tobacco at Euromonitor International, said cannabis will serve as an ingredient in several consumer goods.
The researcher highlighted food, beverages, beauty, health and tobacco as the ones with highest potential of disruption from the growing cannabis market.
At the same time, the industry will continue to experience exponential growth while alcohol and tobacco will grow at a much slower pace, the report says.
“From 2018 to 2025, legal cannabis is estimated to grow more than 2,000 percent globally, compared to alcoholic drinks at 1.4 percent and tobacco at 1.2 percent,” the research firm indicated.
As the cannabis legalization movement continues across the globe, Canadian marijuana firms with first mover status in the industry have moved forward with expansion plans internationally.
Through joint ventures, acquisitions and other business tactics, Canadian cannabis companies pursue ventures across the legal marijuana map.
“Euromonitor International expects global sales of packaged food with CBD to double over the next two years, further blurring the lines between consumer health and food,” the research firm wrote.
Cannabidiol (CBD) has picked up in consumer interest as the product, derived from hemp, finds its way to the US market.
Cannabis companies across the US and Canada have started pursuing operations involving hemp production to enter the CBD market.
Projections for global market value continue rising
Vivien Azer, managing director and senior research analyst specializing in the beverage, tobacco, and cannabis sectors for Cowen, indicated US cannabis sales will reach US$80 billion by 2030.
Similarly, research firm Seaport Global issued its own cannabis report and initiated coverage in several stocks in the market.
“From a little over $12B in global value today, we see the market ultimately evolving to almost $630B in due time,” the firm indicated according to a report from New Cannabis Ventures.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/